Working… Menu

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02494479
Recruitment Status : Completed
First Posted : July 10, 2015
Last Update Posted : July 19, 2017
Information provided by (Responsible Party):
Cellceutix Corporation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2016
Actual Study Completion Date : May 2016